BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18508035)

  • 21. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.
    Xie J; Shults K; Flye L; Jiang F; Head DR; Briggs RC
    J Cell Biochem; 2005 May; 95(2):339-51. PubMed ID: 15778998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
    Bergstralh DT; Sekelsky J
    Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status.
    Sprong D; Janssen HL; Vens C; Begg AC
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):562-72. PubMed ID: 16343804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signatures of DNA double strand breaks produced in irradiated G1 and G2 cells persist into mitosis.
    Kato TA; Okayasu R; Bedford JS
    J Cell Physiol; 2009 Jun; 219(3):760-5. PubMed ID: 19206160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
    de Campos-Nebel M; Larripa I; González-Cid M
    Mutat Res; 2008 Nov; 646(1-2):8-16. PubMed ID: 18812179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
    De Silva IU; McHugh PJ; Clingen PH; Hartley JA
    Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the sensitivity in Chinese hamster cells to photons and fast neutrons by cisplatin, vinblastine, and bleomycin.
    Mokaleng BB; Akudugu JM
    Can J Physiol Pharmacol; 2009 May; 87(5):347-52. PubMed ID: 19448732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of lipoplatin in tumor and in normal cells in vitro.
    Arienti C; Tesei A; Ravaioli A; Ratta M; Carloni S; Mangianti S; Ulivi P; Nicoletti S; Amadori D; Zoli W
    Anticancer Drugs; 2008 Nov; 19(10):983-90. PubMed ID: 18827563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of phosphorylated histone H3 serine 10 and serine 28 cell cycle marker intensities after DNA damage.
    Ozawa K
    Cytometry A; 2008 Jun; 73(6):517-27. PubMed ID: 18395832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin-induced apoptosis in cultures of human Schwann cells.
    Jirsova K; Mandys V; Gispen WH; Bär PR
    Neurosci Lett; 2006 Jan; 392(1-2):22-6. PubMed ID: 16236448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136.
    Clingen PH; De Silva IU; McHugh PJ; Ghadessy FJ; Tilby MJ; Thurston DE; Hartley JA
    Nucleic Acids Res; 2005; 33(10):3283-91. PubMed ID: 15944449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between DNA lesions, DNA repair and chromosomal damage induced by acetaldehyde.
    Lorenti Garcia C; Mechilli M; Proietti De Santis L; Schinoppi A; Kobos K; Palitti F
    Mutat Res; 2009 Mar; 662(1-2):3-9. PubMed ID: 19084543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
    Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
    Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold(III) complexes as a new family of cytotoxic and antitumor agents.
    Marcon G; Messori L; Orioli P
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):337-46. PubMed ID: 12113057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair mechanisms are involved in the hypoxia-dependent toxicity of NLCQ-1 (NSC 709257) and its synergistic interaction with alkylating agents.
    Papadopoulou MV; Bloomer WD
    In Vivo; 2007; 21(2):175-80. PubMed ID: 17436565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy.
    Wynne P; Newton C; Ledermann JA; Olaitan A; Mould TA; Hartley JA
    Br J Cancer; 2007 Oct; 97(7):927-33. PubMed ID: 17848946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.